Khiron Life Sciences Corp. KHRNF

Company Overview

Khiron Life Sciences Corp. is a Canadian-based cannabis and healthcare company focused primarily on medical cannabis products and related healthcare services in Latin America and Europe. The company operates in the regulated medical cannabis industry, with activities spanning cultivation, product development, distribution, and patient-oriented healthcare services. Khiron has historically positioned itself as an integrated operator that combines physician education, patient access, and pharmaceutical-grade cannabis products to support prescription-based medical cannabis treatment.

The company’s principal revenue drivers have included sales of medical cannabis products, healthcare clinic services, and distribution agreements in regulated international markets. Khiron initially built its business around operations in Colombia and later expanded into additional markets including Germany, the United Kingdom, Brazil, and Peru. The company has emphasized physician engagement, regulatory compliance, and pharmaceutical standards as differentiators within emerging international medical cannabis markets. Founded in 2017, Khiron evolved through acquisitions, licensing arrangements, and clinic network development as Latin American medical cannabis regulations advanced.